In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
Some infertility services include Assisted Reproductive Technology (ART), Infertility drug services, Artificial Insemination and Fertility Surgeries.
In 2018, the global Infertility Services market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Infertility Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infertility Services development in United States, Europe and China.
The key players covered in this study
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife
AbbVie
Apricus Biosciences
AstraZeneca
Auxogyn
Eli Lilly
EMD Serono
IKS International
InVitro Care
INVO Bioscience
Irvine Scientific
LifeGlobal
MedITEX
NMC Health
OB GYN Associates
OvaScience
Pantec Biosolutions
Reproductive Medicine Associates of New Jersey
The Sims Clinic
TriHealth
Virtus Health
Xytex Cryo International
Market segment by Type, the product can be split into
Assisted Reproductive Technology (ART)
Infertility drug services
Artificial Insemination
Fertility Surgeries
Market segment by Application, split into
Male
Female
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Infertility Services status, future forecast, growth opportunity, key market and key players.
To present the Infertility Services development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Infertility Services are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Some infertility services include Assisted Reproductive Technology (ART), Infertility drug services, Artificial Insemination and Fertility Surgeries.
In 2018, the global Infertility Services market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Infertility Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infertility Services development in United States, Europe and China.
The key players covered in this study
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife
AbbVie
Apricus Biosciences
AstraZeneca
Auxogyn
Eli Lilly
EMD Serono
IKS International
InVitro Care
INVO Bioscience
Irvine Scientific
LifeGlobal
MedITEX
NMC Health
OB GYN Associates
OvaScience
Pantec Biosolutions
Reproductive Medicine Associates of New Jersey
The Sims Clinic
TriHealth
Virtus Health
Xytex Cryo International
Market segment by Type, the product can be split into
Assisted Reproductive Technology (ART)
Infertility drug services
Artificial Insemination
Fertility Surgeries
Market segment by Application, split into
Male
Female
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Infertility Services status, future forecast, growth opportunity, key market and key players.
To present the Infertility Services development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Infertility Services are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Infertility Services Market Size Growth Rate by Type (2014-2025)
1.4.2 Assisted Reproductive Technology (ART)
1.4.3 Infertility drug services
1.4.4 Artificial Insemination
1.4.5 Fertility Surgeries
1.5 Market by Application
1.5.1 Global Infertility Services Market Share by Application (2014-2025)
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Infertility Services Market Size
2.2 Infertility Services Growth Trends by Regions
2.2.1 Infertility Services Market Size by Regions (2014-2025)
2.2.2 Infertility Services Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Infertility Services Market Size by Manufacturers
3.1.1 Global Infertility Services Revenue by Manufacturers (2014-2019)
3.1.2 Global Infertility Services Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Infertility Services Market Concentration Ratio (CR5 and HHI)
3.2 Infertility Services Key Players Head office and Area Served
3.3 Key Players Infertility Services Product/Solution/Service
3.4 Date of Enter into Infertility Services Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Infertility Services Market Size by Type (2014-2019)
4.2 Global Infertility Services Market Size by Application (2014-2019)
5 United States
5.1 United States Infertility Services Market Size (2014-2019)
5.2 Infertility Services Key Players in United States
5.3 United States Infertility Services Market Size by Type
5.4 United States Infertility Services Market Size by Application
6 Europe
6.1 Europe Infertility Services Market Size (2014-2019)
6.2 Infertility Services Key Players in Europe
6.3 Europe Infertility Services Market Size by Type
6.4 Europe Infertility Services Market Size by Application
7 China
7.1 China Infertility Services Market Size (2014-2019)
7.2 Infertility Services Key Players in China
7.3 China Infertility Services Market Size by Type
7.4 China Infertility Services Market Size by Application
8 Japan
8.1 Japan Infertility Services Market Size (2014-2019)
8.2 Infertility Services Key Players in Japan
8.3 Japan Infertility Services Market Size by Type
8.4 Japan Infertility Services Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Infertility Services Market Size (2014-2019)
9.2 Infertility Services Key Players in Southeast Asia
9.3 Southeast Asia Infertility Services Market Size by Type
9.4 Southeast Asia Infertility Services Market Size by Application
10 India
10.1 India Infertility Services Market Size (2014-2019)
10.2 Infertility Services Key Players in India
10.3 India Infertility Services Market Size by Type
10.4 India Infertility Services Market Size by Application
11 Central & South America
11.1 Central & South America Infertility Services Market Size (2014-2019)
11.2 Infertility Services Key Players in Central & South America
11.3 Central & South America Infertility Services Market Size by Type
11.4 Central & South America Infertility Services Market Size by Application
12 International Players Profiles
12.1 CARE facility
12.1.1 CARE facility Company Details
12.1.2 Company Description and Business Overview
12.1.3 Infertility Services Introduction
12.1.4 CARE facility Revenue in Infertility Services Business (2014-2019)
12.1.5 CARE facility Recent Development
12.2 CooperSurgical
12.2.1 CooperSurgical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Infertility Services Introduction
12.2.4 CooperSurgical Revenue in Infertility Services Business (2014-2019)
12.2.5 CooperSurgical Recent Development
12.3 Ferring Pharmaceuticals
12.3.1 Ferring Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Infertility Services Introduction
12.3.4 Ferring Pharmaceuticals Revenue in Infertility Services Business (2014-2019)
12.3.5 Ferring Pharmaceuticals Recent Development
12.4 Monash IVF
12.4.1 Monash IVF Company Details
12.4.2 Company Description and Business Overview
12.4.3 Infertility Services Introduction
12.4.4 Monash IVF Revenue in Infertility Services Business (2014-2019)
12.4.5 Monash IVF Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Infertility Services Introduction
12.5.4 Merck Revenue in Infertility Services Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Vitrolife
12.6.1 Vitrolife Company Details
12.6.2 Company Description and Business Overview
12.6.3 Infertility Services Introduction
12.6.4 Vitrolife Revenue in Infertility Services Business (2014-2019)
12.6.5 Vitrolife Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Infertility Services Introduction
12.7.4 AbbVie Revenue in Infertility Services Business (2014-2019)
12.7.5 AbbVie Recent Development
12.8 Apricus Biosciences
12.8.1 Apricus Biosciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Infertility Services Introduction
12.8.4 Apricus Biosciences Revenue in Infertility Services Business (2014-2019)
12.8.5 Apricus Biosciences Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Infertility Services Introduction
12.9.4 AstraZeneca Revenue in Infertility Services Business (2014-2019)
12.9.5 AstraZeneca Recent Development
12.10 Auxogyn
12.10.1 Auxogyn Company Details
12.10.2 Company Description and Business Overview
12.10.3 Infertility Services Introduction
12.10.4 Auxogyn Revenue in Infertility Services Business (2014-2019)
12.10.5 Auxogyn Recent Development
12.11 Eli Lilly
12.12 EMD Serono
12.13 IKS International
12.14 InVitro Care
12.15 INVO Bioscience
12.16 Irvine Scientific
12.17 LifeGlobal
12.18 MedITEX
12.19 NMC Health
12.20 OB GYN Associates
12.21 OvaScience
12.22 Pantec Biosolutions
12.23 Reproductive Medicine Associates of New Jersey
12.24 The Sims Clinic
12.25 TriHealth
12.26 Virtus Health
12.27 Xytex Cryo International
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst''s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Infertility Services Market Size Growth Rate by Type (2014-2025)
1.4.2 Assisted Reproductive Technology (ART)
1.4.3 Infertility drug services
1.4.4 Artificial Insemination
1.4.5 Fertility Surgeries
1.5 Market by Application
1.5.1 Global Infertility Services Market Share by Application (2014-2025)
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Infertility Services Market Size
2.2 Infertility Services Growth Trends by Regions
2.2.1 Infertility Services Market Size by Regions (2014-2025)
2.2.2 Infertility Services Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Infertility Services Market Size by Manufacturers
3.1.1 Global Infertility Services Revenue by Manufacturers (2014-2019)
3.1.2 Global Infertility Services Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Infertility Services Market Concentration Ratio (CR5 and HHI)
3.2 Infertility Services Key Players Head office and Area Served
3.3 Key Players Infertility Services Product/Solution/Service
3.4 Date of Enter into Infertility Services Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Infertility Services Market Size by Type (2014-2019)
4.2 Global Infertility Services Market Size by Application (2014-2019)
5 United States
5.1 United States Infertility Services Market Size (2014-2019)
5.2 Infertility Services Key Players in United States
5.3 United States Infertility Services Market Size by Type
5.4 United States Infertility Services Market Size by Application
6 Europe
6.1 Europe Infertility Services Market Size (2014-2019)
6.2 Infertility Services Key Players in Europe
6.3 Europe Infertility Services Market Size by Type
6.4 Europe Infertility Services Market Size by Application
7 China
7.1 China Infertility Services Market Size (2014-2019)
7.2 Infertility Services Key Players in China
7.3 China Infertility Services Market Size by Type
7.4 China Infertility Services Market Size by Application
8 Japan
8.1 Japan Infertility Services Market Size (2014-2019)
8.2 Infertility Services Key Players in Japan
8.3 Japan Infertility Services Market Size by Type
8.4 Japan Infertility Services Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Infertility Services Market Size (2014-2019)
9.2 Infertility Services Key Players in Southeast Asia
9.3 Southeast Asia Infertility Services Market Size by Type
9.4 Southeast Asia Infertility Services Market Size by Application
10 India
10.1 India Infertility Services Market Size (2014-2019)
10.2 Infertility Services Key Players in India
10.3 India Infertility Services Market Size by Type
10.4 India Infertility Services Market Size by Application
11 Central & South America
11.1 Central & South America Infertility Services Market Size (2014-2019)
11.2 Infertility Services Key Players in Central & South America
11.3 Central & South America Infertility Services Market Size by Type
11.4 Central & South America Infertility Services Market Size by Application
12 International Players Profiles
12.1 CARE facility
12.1.1 CARE facility Company Details
12.1.2 Company Description and Business Overview
12.1.3 Infertility Services Introduction
12.1.4 CARE facility Revenue in Infertility Services Business (2014-2019)
12.1.5 CARE facility Recent Development
12.2 CooperSurgical
12.2.1 CooperSurgical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Infertility Services Introduction
12.2.4 CooperSurgical Revenue in Infertility Services Business (2014-2019)
12.2.5 CooperSurgical Recent Development
12.3 Ferring Pharmaceuticals
12.3.1 Ferring Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Infertility Services Introduction
12.3.4 Ferring Pharmaceuticals Revenue in Infertility Services Business (2014-2019)
12.3.5 Ferring Pharmaceuticals Recent Development
12.4 Monash IVF
12.4.1 Monash IVF Company Details
12.4.2 Company Description and Business Overview
12.4.3 Infertility Services Introduction
12.4.4 Monash IVF Revenue in Infertility Services Business (2014-2019)
12.4.5 Monash IVF Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Infertility Services Introduction
12.5.4 Merck Revenue in Infertility Services Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Vitrolife
12.6.1 Vitrolife Company Details
12.6.2 Company Description and Business Overview
12.6.3 Infertility Services Introduction
12.6.4 Vitrolife Revenue in Infertility Services Business (2014-2019)
12.6.5 Vitrolife Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Infertility Services Introduction
12.7.4 AbbVie Revenue in Infertility Services Business (2014-2019)
12.7.5 AbbVie Recent Development
12.8 Apricus Biosciences
12.8.1 Apricus Biosciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Infertility Services Introduction
12.8.4 Apricus Biosciences Revenue in Infertility Services Business (2014-2019)
12.8.5 Apricus Biosciences Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Infertility Services Introduction
12.9.4 AstraZeneca Revenue in Infertility Services Business (2014-2019)
12.9.5 AstraZeneca Recent Development
12.10 Auxogyn
12.10.1 Auxogyn Company Details
12.10.2 Company Description and Business Overview
12.10.3 Infertility Services Introduction
12.10.4 Auxogyn Revenue in Infertility Services Business (2014-2019)
12.10.5 Auxogyn Recent Development
12.11 Eli Lilly
12.12 EMD Serono
12.13 IKS International
12.14 InVitro Care
12.15 INVO Bioscience
12.16 Irvine Scientific
12.17 LifeGlobal
12.18 MedITEX
12.19 NMC Health
12.20 OB GYN Associates
12.21 OvaScience
12.22 Pantec Biosolutions
12.23 Reproductive Medicine Associates of New Jersey
12.24 The Sims Clinic
12.25 TriHealth
12.26 Virtus Health
12.27 Xytex Cryo International
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst''s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
